During the past decade, St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials, followed by "German CLL Study Group" with 4 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Heidelberg University" with 1 trials sponsored and "III. Medizinische Klinik Mannheim" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH" #1 collaborator was "ClinAssess GmbH" with 1 trials as a collaborator, "GELARC Service de Pharmacovigilance, Pierre Benite" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator and "Klinikum der Universitaet Muenchen, Grosshadern" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH" are "Lymphoma" (5 trials), "Leukemia" (4 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Mantle Cell Lymphoma" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH" in a lesser frequency.

Most popular intervention types in "St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH" are "Drug" (16 trials), "Biological" (11 trials), "Radiation" (5 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (7 trials), "doxorubicin hydrochloride" (6 trials), "prednisone" (6 trials), "vincristine sulfate" (6 trials) and "Rituximab" (5 trials). Other intervention names were less common.

The vast majority of trials in "St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH" are 18 trials for "All" genders.

Currently, there are NaN active trials in "St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH has several departments that took part in Clinical trials: "Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie" - 2 trials